Visual Improvement in a Patient Taking Ginkgo Biloba Extract: A Case Study

Explore: The Journal of Science and Healing

Volumn 3, Issue 4, 2007, Pages 391-395

  Dorairaj, Syril ^a   Ritch, Robert ^a,b   Liebmann, Jeffrey M ^c,d  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d EAR AND THROAT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; GINKGO BILOBA EXTRACT; PENTOXIFYLLINE;

AGED; ARTICLE; CASE REPORT; CASE STUDY; CATARACT; DETERIORATION; FOLLOW UP; GONIOSCOPY; HUMAN; INTRAOCULAR PRESSURE; ISCHEMIC OPTIC NEUROPATHY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; SLIT LAMP; STEREOMETRY; VISUAL ACUITY; VISUAL FIELD DEFECT;

AGED; ANTIOXIDANTS; GINKGO BILOBA; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELDS;

EID: 34547558945     PISSN: 15508307     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.explore.2007.04.011     Document Type: Article

References (26)

1. Shields M.B., Ritch R., and Krupin T. Classifications of the glaucomas. In: Ritch R., Shields M.B., and Krupin T. (Eds). The Glaucomas (1996), Mosby, St Louis, Mo 717-725
2. Goldberg I., Hollows F.C., Kass M.A., and Becker B. Systemic factors in patients with low-tension glaucoma. Br J Ophthalmol 65 (1981) 56-62
3. Phelps C.D., and Corbert J.J. Migraine and low-tension glaucoma: a case-control study. Invest Ophthalmol Vis Sci 26 (1985) 1105-1108
4. Gasser P., and Flammer J. Influence of vasospasm on visual function. Doc Ophthalmol 66 (1987) 3-18
5. Wax M.B., Barrett D.A., and Pestronk A. Increased incidence of paraproteinemia and autoantibodies in patients with normal-tension glaucoma. Am J Ophthalmol 117 (1994) 561-568
6. Stroman G.A., Stewart W.C., Golnik K.C., Cure J.K., and Olinger R.E. Magnetic resonance imaging in patients with low-tension glaucoma. Arch Ophthalmol 113 2 (1995) 168-172
7. Yoles E., and Schwartz M. Potential neuroprotective therapy for glaucomatous optic neuropathy. Surv Ophthalmol 42 (1998) 367-372
8. Geyer O., Neudorfer M., Kessler A., Firsteter E., Lazar M., and Almog Y. Effect of oral nifedipine on ocular blood flow in patients with low-tension glaucoma. Br J Ophthalmol 80 (1996) 1060-1062
9. Netland P.A., Feke F.T., Konn S., Goger D.G., and Fujio N. Optic nerve head circulation after topical calcium channel blocker. J Glaucoma 5 (1996) 200-206
10. Zornow M.I., and Prough D.S. Neuroprotective properties of calcium channel blockers. New Horizons 4 (1996) 107
11. Furberg C.D., Psaty B.M., and Meyer J.V. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 92 (1995) 1326-1331
12. Chobanian A.V. Calcium channel blockers: lessons learned from MIDAS and other clinical trials. JAMA 276 (1996) 829-830
13. Ritch R. Potential role for Ginkgo biloba extract in the treatment of glaucoma. Med Hypotheses 54 (2000) 221-235
14. Chang J.Y., and Chang M.N. Medicinal uses of Ginkgo biloba. Today Ther Trends 15 (1997) 63-74
15. Smith P.F., Maclennan K., and Darlington C.L. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol 50 (1996) 131-139
16. Diamond B.J., Shiflett S.C., Feiwel N., et al. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 81 (2000) 668-678
17. Ritch R. Complementary therapy for the treatment of glaucoma: a perspective. Ophthalmol Clin North Am 18 (2005) 597-609
18. Nouri-Mahdavi K., Brigatti I., Weitzman M., and Caprioli J. Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology 102 (1995) 1760-1769
19. Quaranta L., Bettelli S., Uva M.G., Semeraro F., Turano R., and Gandolfo E. Effect of Ginkgo biloba extract on pre-existing visual field damage in normal tension glaucoma. Ophthalmology 110 (2003) 359-362
20. Oyama Y., Fuchs P.A., Katayama N., and Noda K. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons. Brain Res 635 (1994) 125-129
21. Bruno C., Cuppini R., Sartini S., Cecchini T., Ambrogini P., and Bombardelli E. Regeneration of motor nerves in bilobalide-treated rats. Planta Med 59 (1993) 302-307
22. Guidetti C., Paracchini S., Lucchini S., Cambieri M., and Marzatico F. Prevention of neuronal cell damage induced by oxidative stress in vitro: effect of different Ginkgo biloba extracts. J Pharm Pharmacol 53 (2001) 387-392
23. Zhou L.J., and Zhu X.Z. Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. J Pharmacol Exp Ther 293 (2000) 982-988
24. Ahlemeyer B., Mowes A., and Krieglstein J. Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. Eur J Pharmacol 367 (1999) 423-430
25. Zhu L., Wu J., Liao H., Gao J., Zhao X.N., and Zhang Z.X. Antagonistic effects of extract from leaves of Ginkgo biloba on glutamate neurotoxicity. Acta Pharmacol Sinica 18 (1997) 344-347
26. Koltrigner P., Langsteger W., Klima G., Reisecker F., and Eber O. Hemorheologic effects of Ginkgo biloba extract Egb 761. Dose-dependent effect of Egb 761 on microcirculation and viscoelasticity of blood. [In German]. Fortschr der Medizin 111 (1993) 170-172